Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Study Information
Alliance Study ID: NCCTG-N05C7
NCT Study ID (ClinicalTrials.gov): NCT00376675
Disease or Cancer Type: Other Cancer
Alliance Study Chair: Amit Sood, MD
Status: COMPLETED
Study Description
RATIONALE: Methylphenidate may help relieve fatigue caused by cancer. It is not yet known whether methylphenidate is more effective than a placebo in relieving fatigue and improving quality of life in patients with cancer.
PURPOSE: This randomized phase III trial is studying methylphenidate to see how well it works in treating patients with fatigue caused by cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information